| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8219699 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 7 Pages |
Abstract
The risk of LRR for patients with T1,2 breast cancer with 1 to 3 positive lymph nodes treated with mastectomy and systemic treatment is highly dependent on the era of treatment. Modern treatment advances and the selected use of PMRT for those with high-risk features have allowed for identification of a cohort at very low risk for LRR without PMRT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Andrew MD, Pamela PhD, MPH, Wendy MD, PhD, Michelle MD, Henry M. MD, PhD, Eva Katherine MD, Aysegul MD, Eric A. MD, Aman MD, Vicente MD, Gabriel N. MD, Kelly K. BS, MD, Thomas A. MD,